Cargando…
Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
OBJECTIVE: To evaluate the efficacy and safety of rituximab in multiple sclerosis in a clinical practice setting. METHODS: Clinical data for all adult patients with multiple sclerosis (MS) treated with off-label rituximab at a single MS center in Lebanon between March 2008 and April 2017 were retros...
Autores principales: | Yamout, Bassem I., El-Ayoubi, Nabil K., Nicolas, Johny, El Kouzi, Yehya, Khoury, Samia J., Zeineddine, Maya M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260423/ https://www.ncbi.nlm.nih.gov/pubmed/30539030 http://dx.doi.org/10.1155/2018/9084759 |
Ejemplares similares
-
Treatment of multiple sclerosis in special populations: The case of refugees
por: Zeineddine, Maya M, et al.
Publicado: (2020) -
Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients
por: Darwish, Hala, et al.
Publicado: (2017) -
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
por: Yamout, Bassem I, et al.
Publicado: (2021) -
Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy
por: Salzer, Jonatan, et al.
Publicado: (2016) -
Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis
por: El Ayoubi, Nabil K., et al.
Publicado: (2022)